Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patientsZahra Pakbaz, MD 1 *, Roland Fischer, PhD 1 2, Ellen Fung, PhD, RD 1, Peter Nielsen, MD, PhD 2, Paul Harmatz, MD 1, Elliott Vichinsky, MD 11Children's Hospital & Research Center Oakland, Oakland, California2University Medical Center Hamburg-Eppendorf, Hamburg, Germanyemail: Zahra Pakbaz (zpakbaz@mail.cho.org)*Correspondence to Zahra Pakbaz, Children's Hospital & Research Center Oakland, 747 52nd Street, Oakland, CA 94609.Funded by: National Institutes of Health; Grant Number: M01RR01271Keywordsferritin • liver iron concentration • sickle cell • thalassemiaAbstractSerum ferritin (SF) and liver iron concentration (LIC), as measured by SQUID biosusceptometry, were assessed in a convenience sample of transfusion independent thalassemia patients (nTx-Thal, n = 26), regularly transfused thalassemia (Tx-Thal, n = 89), or sickle cell patients (SCD, n = 45) to investigate the severity of iron overload and the relationship between SF and LIC in nTx-Thal compared to SCD and Tx-Thal. SF correlated with LIC (RS = 0.53, P < 0.001), but was found to be a poor predictor for LIC. SF was significantly lower (P < 0.001) in nTx-Thal patients than in other groups, despite similar LIC values. The SF-to-LIC ratio was significantly lower in nTx-Thal compared to Tx-Thal and SCD patients (median of 0.32, 0.87, and 1.2, respectively: P < 0.001). Due to underestimation of LIC by ferritin levels, chelation treatment may be delayed or misdirected in patients with thalassemia intermedia. Pediatr Blood Cancer 2007;49:329-332. © 2007 Wiley-Liss, Inc.
Many patients with thalassemia intermedia are able to survive without transfusion with relatively lowhemoglobin and it seems that using medications such as decitabin, hydroxyurea and erythropoietin can help toincrease their hemoglobin 1-2 grams. However measuring liver iron concentration (using non-invasive and painfree SQUID) in 26 thalassemia intermedia patients who were not transfused showed that these patients couldbecome as iron overloaded as transfused thalassemia patients due to increased iron absorption from theirintestine. This is while these patients had a relatively low serum ferritin. Therefore liver iron concentration needsto be monitored in these individuals regardless of their serum ferritin and they need to consult with a dietician tohave a low iron diet to avoid iron overload and check their liver iron concentration regularly to seek treatmentbefore the iron deposition causes complications.
Liver iron concentrations and urinary hepcidin in ß-thalassemiaLiver iron concentration in patients with thalassemia intermedia was not significantly different from that in patients with thalassemia major, while the serum ferritin levels were statistically significantly different between the two groups In conclusion, we suggest that in thalassemia intermedia, an as yet unknown signal from expanded erythropoiesis strongly suppresses hepcidin production, resulting in increased intestinal iron absorption and eventual parenchymal iron overload. The observation that serum ferritin levels underestimate the severity of iron overload has important implications for iron chelation in patients with thalassemia intermedia. In such patients, serum ferritin levels have little value for the monitoring of iron overload and iron chelation, and alternative assessments such as liver iron concentration by biopsy, superconducting quantum-interference device (SQUID) or magnetic resonance imaging should be used. Moreover, hepcidin measurements may be useful as part of the diagnostic and prognostic evaluation of thalassemia syndromes. In the future, it may be possible to use exogenous hepcidin to restore normal iron homeostasis in patients with thalassemia intermedia